BUY Welspun Corp Ltd — Sachin Janardan Sarvade, IDBI Capital Markets and Securities
bySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesHorizon: Swing (≤2wk)25 Sept 2026via NDTV Profit
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Reliance Industries weightage increased in Jefferies model portfolio; Check the two new inclusions
NewsCnbc-Tv18·6 Oct · 3d ago
Welspun Corp: What could drive the stock over the next 5 years
NewsLivemint·1 Oct · 1w ago
14 smallcap stocks defy market selloff, rally up to 105% in 3 month
NewsEt-Markets·30 Sept · 1w ago
Welspun Corp bets on US, Saudi growth as overall order book rises to ₹45,000 crore
NewsCnbc-Tv18·28 Sept · 2w ago
Welspun Corp long-term story; PB Fintech faces business model reset: Siddhartha Khemka
NewsCnbc-Tv18·25 Sept · 2w ago
The company is acquiring a 2.57% equity stake in Welspun Mauritius Holdings Limited from Welspun Pipes Inc.
BSE · Company Update·30 Sept · 1w ago
Welspun Corp Ltd has incorporated a new wholly-owned subsidiary in Jordan, expanding its international presence.
BSE · Company Update·18 Sept · 3w ago
Buy, Sell Or Hold: Dr Reddy's Labs, BEL, L&T, HDFC Bank, Welspun Corp And Canara Bank — Ask Profit
NewsNdtv-Profit·15 Sept · 3w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Welspun Corp
- BUY — Nuvama Wealth2 Nov 2026 · ~1 year · target ₹2,729 · Active
- BUY — Ansh Jogendra Bhilwar29 Oct 2026 · Same day · target ₹2,730 · SL hit
- BUY — Somil Mehta, Sharekhan28 Oct 2026 · ~3 months · target ₹2,900 · SL hit
- BUY — Kunal Saraogi27 Oct 2026 · ~1 year · target ₹3,100 · Active
- BUY — Arun Kumar Mantri19 Oct 2026 · ~2 weeks · target ₹2,823 · SL hit
More from Sachin Janardan Sarvade, IDBI Capital Markets and Securities
- BUY Gland Pharma11 Nov 2026 · ~1 year · target ₹4,415 · Active
- BUY Sansera Engineering11 Nov 2026 · ~1 year · target ₹6,265 · Active
- BUY Alkem Laboratories9 Nov 2026 · ~2 weeks · target ₹5,730 · Active
- BUY Wockhardt9 Nov 2026 · ~2 weeks · target ₹2,480 · Active
- BUY Venus Pipes & Tubes9 Nov 2026 · ~2 weeks · target ₹2,180 · Active

